The Current Ratio as of December 2024 (TTM) for ANI Pharmaceuticals, Inc. (ANIP) is 2.74

According to ANI Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.74. This represents a change of -22.86% compared to the average of 3.56 of the last 4 quarters.

ANI Pharmaceuticals, Inc. (ANIP) Historical Current Ratio (quarterly & annually)

How has ANIP Current Ratio performed in the past?

The mean historical Current Ratio of ANI Pharmaceuticals, Inc. over the last ten years is 5.52. The current 2.74 Current Ratio has changed 4.87% with respect to the historical average. Over the past ten years (40 quarters), ANIP's Current Ratio was at its highest in in the June 2015 quarter at 30.07. The Current Ratio was at its lowest in in the March 2019 quarter at 0.92.

ANI Pharmaceuticals, Inc. (ANIP) Current Ratio by Quarter and Year

Discovering the peaks and valleys of ANI Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ANI Pharmaceuticals, Inc. (ANIP) Average Current Ratio

How has ANIP Current Ratio performed in the past?

The current Current Ratio of ANI Pharmaceuticals, Inc. (ANIP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ANI Pharmaceuticals, Inc. (ANIP) Current Ratio vs. Peers

How is ANIP’s Current Ratio compared to its peers?

ANI Pharmaceuticals, Inc.’s Current Ratio is greater than Eagle Pharmaceuticals, Inc. (1.70), less than Phibro Animal Health Corporation (3.23), less than Deciphera Pharmaceuticals, Inc. (4.19), less than Prestige Consumer Healthcare Inc. (3.56), less than Alkermes plc (3.45), greater than Dr. Reddy's Laboratories Limited (1.92), greater than Collegium Pharmaceutical, Inc. (0.97), greater than Pacira BioSciences, Inc. (2.25), greater than Procaps Group S.A. (1.47), greater than Silver Spike Investment Corp. (0), less than Neurocrine Biosciences, Inc. (4.37), less than Amphastar Pharmaceuticals, Inc. (3.43), less than Ironwood Pharmaceuticals, Inc. (3.62), greater than InterCure Ltd. (1.78),

Build a custom stock screener for ANI Pharmaceuticals, Inc. (ANIP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ANI Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ANI Pharmaceuticals, Inc. (ANIP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ANI Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.